The biochemical diagnosis of acromegaly: revising the role of measurement of IGF-I and GH after glucose load in 5 questions

Expert Rev Endocrinol Metab. 2022 May;17(3):205-224. doi: 10.1080/17446651.2022.2069558. Epub 2022 Apr 29.

Abstract

Introduction: Acromegaly is a rare disorder characterized by the excessive secretion of growth hormone (GH), mostly caused by pituitary adenomas. While in full-blown cases the diagnosis is easy to establish, milder cases are more challenging. Additionally, establishing whether full cure after surgery is reached may be difficult.

Areas covered: In this article, we will review the challenges posed by the variability in measurements of GH and its main effector insulin-like growth factor I (IGF-I) due to both biological changes, co-morbidities, and assays variability.

Expert opinion: Interpretation of GH and IGF-I assays is important in establishing an early diagnosis of acromegaly, in avoiding misdiagnosis, and in establishing if cure is achieved by surgery. Physicians should be familiar with the variables that affect measurements of these 2 hormones, and with the performance of the assays available in their practice.

Keywords: Acromegaly; IGF-I; binding proteins; body mass index; competitive assay; growth hormone; sandwich assay.

Publication types

  • Review

MeSH terms

  • Acromegaly* / diagnosis
  • Glucose
  • Human Growth Hormone* / analysis
  • Humans
  • Insulin-Like Growth Factor I* / analysis

Substances

  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Glucose